Focal uptake on a scan refers to a concentrated spot where the imaging tracer has accumulated more than in surrounding tissue, and it signals that something metabolically active is happening at that location. On the most common type of scan where this phrase comes up, an FDG-PET/CT, it means a cluster of cells is burning through glucose at an unusually high rate. That could be cancer, but it could also be infection, inflammation, normal muscle activity, or even brown fat doing its job on a cold day. The phrase itself is descriptive, not diagnostic, and what matters is the context around it.
Why Certain Cells Light Up
FDG-PET/CT works by injecting a glucose molecule tagged with a small amount of radioactive fluorine. Cells that are metabolically hungry grab this tagged sugar the same way they grab regular glucose, but once inside the cell, the tracer gets stuck. It can’t be broken down further, so it accumulates and emits a signal the scanner detects. The more metabolically active a group of cells is, the brighter it appears on the image.
Cancer cells are famously greedy for glucose. Research has shown that malignant lung lesions, for instance, express higher levels of the glucose transporter protein Glut-1 and the enzyme hexokinase-II compared to nonmalignant lesions, and that these molecular markers correlate with tracer uptake intensity.1PubMed Central. [18F]FDG Uptake and PCNA, Glut-1, and Hexokinase-II Expressions in Cancers and Inflammatory Lesions of the Lung Poorly differentiated cancers, which tend to be more aggressive, showed even higher expression of these proteins than well-differentiated ones. But cancer isn’t the only thing that burns through glucose quickly. That same study found a positive relationship between the degree of inflammation in nonmalignant lesions and how much tracer they absorbed. Immune cells fighting an infection or reacting to tissue damage are metabolically active too, and they light up for the same basic reason tumors do.
Focal Versus Diffuse Patterns
One of the first things a radiologist looks at is whether the uptake is focal (concentrated in one spot) or diffuse (spread across a larger region). This distinction matters a great deal for the clinical workup that follows. In the thyroid gland, for example, diffuse uptake across the entire gland is most commonly benign and typically points to chronic thyroiditis, an autoimmune condition. Focal uptake in the thyroid, by contrast, carries a substantially higher risk of malignancy, estimated at roughly 30 to 50 percent.2PET Clinics. Clinical Significance of Incidental Focal Versus Diffuse Thyroid Uptake on FDG-PET Imaging
The same focal-versus-diffuse logic applies in other organs. In the bowel, scattered low-level uptake is often just normal gut activity. A single bright focal spot in the colon, however, deserves investigation. One study found that incidental focal bowel uptake frequently turned out to be adenomas or other premalignant lesions, and the researchers concluded that these foci should not be dismissed as normal physiology.3PubMed. Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results Early detection and removal of such lesions can prevent the development of cancer down the line.
This pattern distinction also helps in settings far removed from oncology. When evaluating infections around prosthetic heart valves or implanted cardiac devices, uptake that is focal at a specific site points toward infection, while homogeneous uptake around the device is more consistent with the normal inflammation that follows surgery.4Heart, Vessels and Transplantation. Imaging for prosthetic valve endocarditis and cardiac implantable electronic device related infections/endocarditis
Common Benign Causes of Focal Uptake
Not every hot spot is worrisome, and understanding the common benign causes can save a lot of unnecessary anxiety. PET/CT has a reported false-positive rate around 13 percent, with most false positives caused by inflammatory cells gathering at sites of infection or other irritation.5CHEST. Endobronchial Foreign Body Mimicking Lung Malignancy on PET/CT Scan Granulomas, healing fractures, post-surgical changes, and foreign bodies can all produce bright focal signals that look suspicious on the scan but have nothing to do with cancer.
Muscles are another frequent culprit. If you talk, chew gum, read a book, tap your feet nervously, or strain your neck while lying on the scanner’s stretcher, the muscles you activate will take up tracer. A study cataloguing physiological muscle uptake found patterns including jaw muscles from chewing, vocal cord uptake from talking during the preparation period, chest wall uptake from labored breathing, forearm uptake from reading, and neck muscle uptake from patients lifting their heads to speak to the technologist.6Journal of Nuclear Medicine Technology. Prevalence and Patterns of Physiologic Muscle Uptake Detected with Whole-Body 18F-FDG PET These findings are usually recognizable by their symmetry and anatomical location, but they can occasionally confuse the picture.
Brown fat is another well-known source of false-positive uptake. Brown fat is metabolically active tissue that generates heat, and it tends to light up on PET scans when a patient has been exposed to cold before or during the scan. It commonly appears in the neck, above the collarbones, and along the spine. Research has confirmed that lower outdoor temperatures increase brown fat uptake in several body regions.7PubMed Central. Brown fat FDG Uptake – A Common Finding in FDG PET CT Scan and the Relation to Demographic, Environmental, and Clinical Factors Keeping patients in a warm environment before the scan effectively reduces this problem without medication.8PubMed. Effective reduction of brown fat FDG uptake by controlling environmental temperature prior to PET scan: an expanded case series
The SUV Number and Why It’s Not a Simple Cutoff
If you’ve seen your scan report, you may have noticed a number called the SUV, or standardized uptake value. This is a measure of how much tracer a particular spot has absorbed relative to what you’d expect if the tracer were evenly distributed throughout your body. A higher SUV generally means more metabolic activity. For years, an SUV of 2.5 was used as a rough dividing line: above it, suspect cancer; below it, probably benign.
That simple threshold has been widely challenged. Research has found that using a single cutoff of 2.5 regardless of where the uptake occurs leads to decreased accuracy, because the normal metabolic activity and the threshold for suspicion vary by organ and tissue type.9Medical Research Archives. The use of the optimized standard uptake value – SUVopt – in the interpretation of FDG PET-CT IN Adrenal Gland and Pleural Based Malignancy A lesion with an SUV of 3.0 in the adrenal gland may mean something quite different from an SUV of 3.0 in the lung or bowel.
For focal thyroid uptake discovered incidentally, one large study of 788 patients found that a nodule SUVmax cutoff of 5.5 provided good discrimination for separating malignant from benign thyroid nodules, with an overall discrimination ability in the 80 to 90 percent range.10PubMed Central. Comparison of incidentally detected focal FDG uptake in the thyroid gland on PET/CT with fine needle aspiration biopsy results That’s more than double the old blanket threshold of 2.5. The takeaway is that SUV is useful as one piece of the puzzle, but interpreting it requires knowing where the uptake is and what the surrounding tissue normally looks like.
How Blood Sugar and Preparation Affect Results
Because the FDG tracer is essentially a sugar molecule, your blood glucose level at the time of the scan matters. High blood sugar competes with the tracer for entry into cells, which can dilute the signal from a tumor and make it harder to detect. That’s why you’re asked to fast before a PET scan.
A systematic review of blood glucose effects found that the brain’s tracer uptake was significantly and inversely related to blood sugar levels, meaning higher glucose meant less brain uptake. The liver and blood pool were also affected, though to a smaller degree. Interestingly, tumor uptake as a group was not significantly affected by blood glucose in that analysis, though individual variation was substantial, and body mass appeared to be another important factor influencing uptake.11PubMed Central. Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review
Other research paints a somewhat different picture for specific organs. One study found that above a blood glucose level of about 160 mg/dL, liver and bone uptake progressively dropped, making scans less reliable in patients with poorly controlled diabetes.12Iraqi Journal of Physics. Assessment of the Effect of Blood Glucose Levels on Standardized Uptake Value (SUV) and 18F-FDG Uptake at Tumors and Normal PET Examinations In diabetic patients, hyperglycemia can also shift the tracer distribution, increasing uptake in muscles and soft tissues and degrading overall image quality.13PubMed Central. Utility of Short-Acting Intravenous Insulin Therapy in Preparation of F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography Scan in Cancer Patients Incidentally Detected with High Blood Glucose Levels on the Day of Test This is why imaging centers check your blood sugar before injecting the tracer and may reschedule your scan if it’s too high.
Artifacts That Mimic Real Uptake
Not every bright spot on a PET/CT scan reflects biology. Technical artifacts can create the appearance of focal uptake where none really exists. One common source is contrast material used during the CT portion of the exam. Contrast agents are designed to absorb X-ray energy at CT photon levels, but when the scanner uses the CT image to correct the PET data, the presence of dense contrast material can lead to an overestimate of tracer activity in that region, creating a false hot spot.14PubMed Central. Pitfalls on PET/CT due to artifacts and instrumentation Radiologists are trained to recognize these artifacts, often by comparing the corrected images with uncorrected versions, but they can occasionally trip up an initial read.
Patient movement between the CT and PET acquisitions can also cause problems. If you shift position even slightly, the two image sets won’t line up perfectly, and a hot spot may appear to be in the wrong place or blend with an adjacent structure. Metallic implants, dental fillings, and other high-density objects can similarly distort the correction process. These are the kinds of pitfalls that make PET/CT interpretation as much art as science and explain why the reports often include a line about correlation with clinical history.
When Focal Uptake Is Found by Accident
Plenty of focal uptake is not what the scan was ordered for. You might get a PET/CT to stage a known lung cancer and the radiologist spots a bright area in your thyroid, your colon, or an adrenal gland. These are called incidental findings, and they’re common. One study reviewing over 3,000 PET/CT scans found that about 8 percent of patients had some form of incidental thyroid uptake.15PubMed Central. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer When focal thyroid uptake is found incidentally, the standard approach at many centers is to recommend a thyroid ultrasound. If the ultrasound shows a nodule with low-suspicion features and it’s small, clinical monitoring without biopsy is often appropriate.16Journal of Nuclear Medicine. Focal Thyroid Lesions Incidentally Identified by Integrated 18F-FDG PET/CT: Clinical Significance and Improved Characterization
Thyroid scintigraphy, a separate nuclear medicine test that maps how thyroid tissue takes up iodine, adds another layer of information. Among patients with indeterminate thyroid biopsy results who turned out to have cancer, about 90 percent had a “cold” nodule on scintigraphy, meaning the nodule did not take up iodine normally.17PubMed. Indeterminate thyroid cytology in an iodine-deficient population: Prevalence, operation rate, risk of malignancy and diagnostic value of thyroid scintigraphy and (18)F-FDG PET imaging parameters Combining FDG-PET findings with scintigraphy and ultrasound helps doctors avoid unnecessary surgery. One study found that using ultrasound classification alone, without scintigraphy, increased the rate of suspicious-looking nodules that were ultimately benign, with none of the surgically removed nodules in their cohort turning out to be malignant.18Journal of Nuclear Medicine. Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions
The Cascade Effect of Incidental Findings
Finding a focal hot spot you weren’t looking for creates a real dilemma. Ignoring it could mean missing an early cancer. Pursuing it can trigger what ethicists call a “cascade effect,” where one finding leads to another test, which leads to another, sometimes culminating in procedures with their own risks. Research into the management of incidental brain findings illustrates the tension well: even when a finding turns out to be real, such as an unruptured brain aneurysm, the standard treatments carry meaningful adverse outcome rates, and many incidental findings would never have caused symptoms in the patient’s lifetime.19PubMed Central. A Just Standard: The Ethical Management of Incidental Findings in Brain Imaging Research
Anxiety is another factor. Some researchers have hypothesized that simply disclosing an incidental finding could cause psychological harm, though evidence on this point is mixed. Surveys of stakeholders have found broad support for full disclosure of incidental findings in research imaging, even as experts acknowledge the potential for unnecessary worry and follow-up procedures of unclear benefit.20PubMed Central. Stakeholder Opinions And Ethical Perspectives Support Complete Disclosure Of Incidental Findings In MRI Research In clinical practice, the answer is usually to investigate focal uptake systematically rather than reflexively, weighing the patient’s overall health, the location and intensity of the uptake, and what the CT component of the scan shows.
Focal Uptake in Vascular and Inflammatory Disease
Focal uptake isn’t limited to cancer investigations. FDG-PET/CT has become an increasingly useful tool for diagnosing and monitoring inflammatory conditions of the blood vessels. In large-vessel vasculitis, a group of diseases where the immune system attacks the walls of major arteries, FDG accumulates at the inflamed vessel walls and creates focal or segmental patterns that help clinicians map the extent of the disease.21PubMed Central. Vascular findings on FDG PET/CT Atherosclerotic plaques, particularly unstable ones with active inflammation, can also light up on PET scans, though distinguishing plaque inflammation from vasculitis requires careful pattern analysis.
Newer tracers are pushing the boundaries of what vascular imaging can reveal. A study using a tracer targeting a specific inflammatory protein (TSPO) found that it could detect vascular inflammation in large-vessel vasculitis patients with significantly higher uptake than in healthy controls, and kinetic modeling confirmed that the signal was specific to inflammatory binding rather than nonspecific accumulation.22PubMed. Translocator Protein 18 kDa-Targeted Total-Body PET Imaging Reveals Immune-Specific Vascular Inflammation in Large-Vessel Vasculitis This kind of tracer specificity could eventually help distinguish between different types of vascular inflammation that all look similar on a standard FDG scan.
Focal Uptake in the Brain
In neuroimaging, focal uptake on a PET scan sometimes means the opposite of what it means elsewhere in the body. When evaluating epilepsy, for example, doctors look for areas of decreased uptake rather than increased uptake. Between seizures, the brain region responsible for generating seizures typically shows lower-than-normal glucose metabolism, creating a focal “cold spot.” Interictal FDG-PET has been shown to be more sensitive than some other imaging techniques for localizing the seizure focus in patients whose MRI and EEG results are inconclusive.23PubMed Central. PET studies in epilepsy
Standard clinical PET scans for epilepsy capture a single static snapshot of brain metabolism, but a newer dynamic approach captures the tracer’s behavior over time. In a pilot study, dynamic FDG-PET identified focal regions of altered metabolism in every patient whose standard static scan had appeared normal.24PubMed Central. Dynamic FDG-PET in localization of focal epilepsy: A pilot study Quantitative analysis techniques for both PET and SPECT have generally improved the ability to pinpoint epilepsy onset zones.25PubMed. The Role of SPECT and PET in Epilepsy For patients considering surgery to control drug-resistant seizures, this kind of information can be the deciding factor in whether an operation is feasible and where the surgeon should operate.
Beyond FDG and the Rise of Theranostics
FDG is the most widely used PET tracer, but it is far from the only one, and different tracers create different patterns of focal uptake depending on what molecular target they bind to. In prostate cancer, for instance, PSMA-targeted tracers home in on a protein overexpressed on prostate cancer cells, and focal PSMA uptake can identify metastases that FDG might miss entirely because many prostate cancers are not particularly glucose-hungry. In neuroendocrine tumors, DOTATATE-PET targets somatostatin receptors on tumor cells. The significance of focal uptake depends heavily on which tracer was used and what it was designed to find.
What makes this landscape even more interesting is theranostics, where the same molecular target used for imaging can also be used for treatment. Radioligand therapies targeting somatostatin receptors and PSMA have already shown meaningful clinical benefits, and newer radioactive compounds are being evaluated in clinical trials for conditions like radioiodine-refractory thyroid cancer.26PubMed Central. Recent advances in theranostics and oncology PET: emerging radionuclides and targets In that model, focal uptake on an imaging scan doesn’t just diagnose the disease; it confirms the tumor expresses the target, which predicts whether a matched therapy will work. Research in metastatic prostate cancer, for instance, is exploring how the combination of FDG, PSMA, and DOTATATE uptake patterns can characterize tumor biology and inform treatment decisions.27PubMed. Prognostic value of FDG, PSMA, and DOTATATE uptake on PET imaging in metastatic castration-resistant prostate cancer (mCRPC) In thyroid cancer patients whose tumors no longer respond to radioiodine and don’t show up on iodine scans, DOTATATE and PSMA imaging have been explored to assess whether patients might qualify for alternative radionuclide therapies.28PubMed. Assessing Krenning’s score on 68 Ga-DOTATATE PET-CT and miPSMA score on 68 Ga-PSMA-11 PET-CT in TENIS
The practical implication for patients is straightforward: if your scan report mentions focal uptake, the type of tracer used is just as important as where the hot spot appeared. An FDG-avid focus in the liver tells a different story than a PSMA-avid focus in the same location. The conversation with your doctor should always include which tracer was used and what it was looking for.